ISSN:
2181-3906
2025
International scientific journal
«MODERN SCIENCE АND RESEARCH»
VOLUME 4 / ISSUE 4 / UIF:8.2 / MODERNSCIENCE.UZ
165
INFLAMMATION AND IMMUNOLOGICAL MECHANISM IN MYOCARDIAL
INFARCTION
Husniddin Umurqulov
Assistant of the Departament of Pathology and Forensic Medicine,
Central Asian Medical University.
umurqulovhusnoiddinO@gmail.com
https://doi.org/10.5281/zenodo.15150885
Abstract.
This article examines the role of inflammation and immunological mechanisms
in myocardial infarction. The results of the study show that inflammation and the immune
response in the process of myocardial infarction are a complex, multi-stage process. The
inflammatory reaction affects tissue damage in the infarct zone and the remodeling of the heart
muscle. At the initial stage, mediators released from damaged cells activate the immune system,
which can enhance the processes of necrosis and fibrosis. The immunological response also
plays an important role in the cleansing and regeneration of the myocardial infarction site, but
excessive inflammation and immune response can increase the risk of heart failure.
Keywords:
Myocardial infarction, Immunological mechanism, Cytokines, TNF-α, IL-1, C-
reactive protein (CRP), DAMPs.
ВОСПАЛЕНИЕ И ИММУНОЛОГИЧЕСКИЙ МЕХАНИЗМ ПРИ ИНФАРКТЕ
МИОКАРДА
Аннотация.
В статье рассматривается роль воспаления и иммунологических
механизмов при инфаркте миокарда. Результаты исследований показывают, что
воспаление и иммунный ответ при инфаркте миокарда — сложный, многоэтапный
процесс. Воспалительная реакция влияет на повреждение тканей и ремоделирование
сердечной мышцы в зоне инфаркта. Медиаторы, высвобождаемые из поврежденных
клеток на начальном этапе, активируют иммунную систему, что может усилить
процессы некроза и фиброза. Также иммунологический ответ играет важную роль в
процессе очищения и регенерации места инфаркта миокарда, однако чрезмерное
воспаление и иммунный ответ могут увеличить риск сердечной недостаточности.
Ключевые слова:
Инфаркт миокарда, Иммунологический механизм, Цитокины,
ФНО-α, ИЛ-1, С-реактивный белок (СРБ), DAMP.
ISSN:
2181-3906
2025
International scientific journal
«MODERN SCIENCE АND RESEARCH»
VOLUME 4 / ISSUE 4 / UIF:8.2 / MODERNSCIENCE.UZ
166
Introduction
Myocardial infarction (MI) is one of the severe cardiovascular diseases that develops as a
result of a sharp disruption of the blood supply to the heart muscle, which is part of the acute
coronary syndromes. This pathology is one of the leading causes of death and disability
worldwide, and the issue of improving its treatment and prevention is urgent. The pathogenesis
of MI is a complex and multifactorial process in which inflammatory and immunological
mechanisms play an important role. As a result of ischemia of the heart muscle, necrosis
develops and an inflammatory reaction begins in the damaged tissues. In this process, cells of the
immune system and inflammatory mediators are activated, affecting the process of myocardial
regeneration.
However, excessive inflammation and an imbalance of the immune response can
aggravate myocardial damage and lead to functional failure of the heart. This article analyzes the
role of inflammatory and immunological mechanisms in myocardial infarction, their
interrelationships, and new approaches to treatment. A deeper study of these mechanisms is
important in developing new therapeutic strategies for myocardial infarction.
Literature review and method
Myocardial infarction is a cardiovascular disease that occurs as a result of an acute
disruption of the blood supply to the heart muscle, and its pathogenesis is based on complex
mechanisms. Inflammatory and immunological mechanisms play an important role in this
process.
When myocardial infarction begins, the inflammatory process is activated in the damaged
heart muscle. Damage signals are released from ischemic cells, and this process leads to the
secretion of inflammatory mediators. As a result, the inflammatory process develops and various
cells of the immune system are involved.
Immunological mechanisms include responses aimed at eliminating necrotic tissue in the
infarct zone by the div's defense system. In this process, innate and adaptive immune responses
are formed. Components of the immune system are activated to clean and restore damaged
tissues.
However, uncontrolled or excessive inflammation can lead to further damage to the
myocardium. The interaction of inflammation and immunological mechanisms also affects the
process of remodeling in the heart tissue in the later stages of myocardial infarction. During this
process, myocardial fibrosis and heart failure may develop.
ISSN:
2181-3906
2025
International scientific journal
«MODERN SCIENCE АND RESEARCH»
VOLUME 4 / ISSUE 4 / UIF:8.2 / MODERNSCIENCE.UZ
167
Regulation of inflammation and immunological mechanisms in myocardial infarction is
important for increasing the effectiveness of treatment. By controlling these processes, it is
possible to reduce damage to the heart muscle and prevent complications. In this regard,
biological drugs and immunomodulators are used in modern medicine.
Pathophysiology of myocardial infarction
Myocardial infarction occurs as a result of rupture of atherosclerotic plaques or the
formation of a thrombus in the coronary arteries supplying the heart with blood. This leads to a
sharp cessation of blood flow and the ischemic process begins in the myocardial tissues. In the
initial stage of ischemia, the cell cannot meet the need for oxygen to produce energy, and as a
result, metabolic processes are disrupted. As a result of cell damage, membrane stability is lost,
ion balance is disturbed, and cells undergo necrosis.
Inflammatory process
With the onset of myocardial infarction, the inflammatory process is activated. This
process occurs in interconnected sequential stages:
- Initial phase (last few hours): As a result of myocardial ischemia and necrosis, damage
signaling molecules (DAMPs — damage-associated molecular patterns) are released from cells.
These substances act as signals that stimulate the inflammatory response in the div.
DAMPs activate various cells of the immune system (neutrophils, monocytes and macrophages).
- Inflammatory phase (1-3 days): During this phase, inflammatory mediators (cytokines
and chemokines) are produced. Cytokines such as IL-1, IL-6, TNF-α cause the recruitment of
more immune cells to the infarct zone. Neutrophils phagocytose damaged cells, further
intensifying inflammation. During this process, proteolytic enzymes and oxygen radicals are
released, which play an important role in the destruction of necrotic tissue.
- Clearing phase (3-7 days): In this phase, macrophages are formed from monocytes,
which engulf and clear necrotic cells. Macrophages begin the process of repairing and renewing
damaged tissues. During this period, the amount of cytokines decreases, the inflammatory
process subsides.
- Regeneration phase (7-14 days): Fibroblasts are activated, produce collagen, and
connective tissue is formed. This process leads to the development of fibrosis, which plays an
important role in the closure of the myocardial wound. Inflammation ends, but myocardial
remodeling continues in the remaining focus.
Immunological mechanisms
ISSN:
2181-3906
2025
International scientific journal
«MODERN SCIENCE АND RESEARCH»
VOLUME 4 / ISSUE 4 / UIF:8.2 / MODERNSCIENCE.UZ
168
The pathogenesis of MI involves both innate and adaptive components of the immune
response. The initiation and continuation of the inflammatory process are controlled by these
immune mechanisms:
- Innate immune response: Innate immune cells (neutrophils, macrophages, dendritic
cells), activated by DAMPs and PAMPs (pathogen-associated molecular patterns), enter the
infarct zone and eliminate necrotic cells. These cells produce inflammatory mediators and
activate the inflammatory process.
- Adaptive immune response: Dendritic cells activate T-lymphocytes as antigen-
presenting cells. T-lymphocytes recognize myocardial antigens and form a specific immune
response. During this process, autoimmune reactions may develop, which increases the
likelihood of exacerbation of post-infarction complications.
- Autoimmune reactions: In some cases, myocardial antigens are recognized as
autoantigens and are mistakenly attacked by the immune system. This process can cause
additional damage to the heart tissue.
The role of inflammation and the immune response in the pathogenesis of MI
Inflammation and the immune response play different roles in the acute and chronic
phases of myocardial infarction. While inflammation in the acute phase helps to eliminate
damaged tissues, excessive or prolonged inflammation can increase myocardial remodeling and
fibrosis in the infarcted areas. This can reduce the contractility of the heart muscle and lead to the
development of heart failure.
Management of inflammation and immunity in treatment
Regulation of inflammatory and immunological mechanisms in the treatment of MI is
important to increase the effectiveness of treatment.
- Anti-inflammatory drugs: Drugs that inhibit the activity of cytokines and chemokines
are used.
- Biological drugs: Targeted immunotherapy blocks harmful mediators using specific
antibodies.
- Immunomodulators: Agents that regulate the immune response are used in the acute
phase of infarction.
- Gene and cell therapy: New treatments serve to reduce the consequences of MI.
Inflammatory and immunological mechanisms in myocardial infarction involve complex
processes.
ISSN:
2181-3906
2025
International scientific journal
«MODERN SCIENCE АND RESEARCH»
VOLUME 4 / ISSUE 4 / UIF:8.2 / MODERNSCIENCE.UZ
169
Aberrant activation of these mechanisms can aggravate myocardial damage and lead to
heart failure. Therefore, controlling inflammation and the immune response is important in
treatment. New approaches and therapeutic strategies have great prospects in this area.
Analysis of the scientific literature on the pathogenesis of myocardial infarction (MI), its
inflammatory and immunological mechanisms shows that this pathology is a complex and multi-
stage process. In recent years, the role of inflammatory mediators, immune cells and
autoimmune reactions in the development of MI has been studied in depth. Many studies have
noted that the inflammatory process plays an important role not only in the acute phase of
infarction, but also in the development of long-term complications.
Scientific articles are devoted to the study of the activity of interleukins (IL-1, IL-6),
tumor necrosis factor alpha (TNF-α), C-reactive protein (CRP), neutrophils and macrophages
during MI.
The presence of these mediators in high concentrations is used as one of the diagnostic
biomarkers to determine the severity of the acute phase of infarction, inflammation and fibrosis.
Also, the effect of the immune response on the processes of recovery and remodeling in
the later stages of myocardial injury has been studied.
The literature discusses the effectiveness of biological drugs, cytokine antagonists,
immunomodulators and targeted therapy agents in the treatment of MI. Also, the potential of
gene therapy and cell therapy in the management of inflammatory and immunological responses
has been noted.
Discussion
Studies on the role of inflammation and immunological mechanisms in myocardial
infarction show that these processes are complex and multistage. The results of the study allowed
us to further understand how inflammatory and immunological responses affect the pathogenesis
of myocardial infarction and its complications. In the initial stage of the inflammatory process,
DAMPs and other mediators released from damaged cells in the infarct zone activate the
immune system. As a result of the accumulation of neutrophils, macrophages, and monocytes in
the infarct zone and the release of harmful enzymes, the necrotic focus of the myocardium can
further expand.
This, in turn, reduces the contractile function of the heart muscle and increases the risk of
heart failure. Studies show that controlling inflammation and the immune response at the initial
stage can reduce the damage caused by myocardial infarction.
ISSN:
2181-3906
2025
International scientific journal
«MODERN SCIENCE АND RESEARCH»
VOLUME 4 / ISSUE 4 / UIF:8.2 / MODERNSCIENCE.UZ
170
For example, high levels of inflammatory mediators such as interleukins (IL-1, IL-6),
TNF-α, and C-reactive protein (CRP) increase necrosis and fibrosis processes in the infarct site.
Therefore, biological drugs that inhibit their activity (for example, IL-1 antagonists or
TNF-α blockers) are of great importance in treatment. Immunological mechanisms play an
important role in the process of clearing and regeneration of necrotic tissue in the infarct site.
However, excessive or prolonged inflammation can negatively affect myocardial
remodeling and lead to the development of heart failure.
Therefore, balancing inflammation and immune responses is important in increasing the
effectiveness of treatment. Based on the analyzed scientific sources, it has been established that
excessive activity of inflammation and immunological responses in the pathogenesis of MI
exacerbates the damage caused by infarction. Prolonged inflammation leads to fibrosis of the
heart muscle, decreased contractile function of the heart, and increases the risk of heart failure.
Therefore, the timely use of anti-inflammatory and immunomodulatory agents provides
positive results in the treatment of MI. The results of the study confirm the need to develop new
therapeutic strategies that target inflammatory and immunological mechanisms in myocardial
infarction. In particular, the use of new methods, such as biological drugs that regulate the
activity of cytokines and inflammatory mediators, gene and cell therapy, can help reduce the
consequences of MI. In conclusion, the study of inflammatory and immunological mechanisms
in myocardial infarction allows the development of effective strategies to reduce myocardial
damage and accelerate recovery processes. Research in this area is of great importance in
improving modern treatment methods and introducing new approaches.
Conclusion
Inflammatory and immunological mechanisms in myocardial infarction significantly
affect the development of pathology through complex and multi-stage processes. The
interrelation of these processes leads to tissue damage in the acute phase of infarction, and in the
long term to remodeling and fibrosis of the heart muscle. The results of the study show that
balanced control of inflammation and immune response is important in reducing the
consequences of myocardial infarction. In the initial stage of the inflammatory process, the
activation of the immune system by DAMPs and other mediators helps to eliminate necrosis and
damaged tissues in the infarct focus.
However, excessive or prolonged inflammation causes additional damage to myocardial
tissue and increases the risk of heart failure.
ISSN:
2181-3906
2025
International scientific journal
«MODERN SCIENCE АND RESEARCH»
VOLUME 4 / ISSUE 4 / UIF:8.2 / MODERNSCIENCE.UZ
171
As a result of excessive activity of immunological mechanisms, autoimmune reactions
and chronic inflammation are observed, which can further aggravate the complications of
infarction. Therefore, there is a need for targeted control of inflammatory mediators and the
immune response in treatment.
The use of anti-inflammatory biological drugs, cytokine antagonists, immunomodulators
and targeted therapy agents may be effective in alleviating the consequences of myocardial
infarction. The potential of gene and cell therapy in controlling the immune response is very
promising.
Overall, further understanding of the inflammatory and immunological mechanisms of
myocardial infarction and improving treatment options will play a key role in reducing mortality
and disability from cardiovascular disease. Future research in this area will help develop new
therapeutic strategies.
REFERENCES
1.
Yaminova N.Kh. "Myocardial infarction - causes, symptoms, risk factors, first aid and
treatment." Andijan State Medical Institute. May 23, 2023.
2.
Usmonova N.I. "Myocardial infarction - causes, symptoms, risk factors, first aid and
treatment." Education science and innovative ideas in the world, 2024.
3.
"Myocardial infarction - causes, symptoms, first aid and treatment." MyMedic.
4.
"Myocardial infarction." Wikipedia.
5.
"Clinical and immunological signs of chronic inflammation in patients with chronic heart
failure who have had myocardial infarction."
6.
"Cardiovascular rehabilitation. Myocardial infarction." IUPR.ru.
